Helius Medical Tech Q2 EPS $(0.06) Beats $(0.12) Estimate, Sales $256.00K Beat $190.00K Estimate
Portfolio Pulse from totan@benzinga.com
Helius Medical Tech (NASDAQ:HSDT) reported Q2 losses of $(0.06) per share, beating the analyst consensus estimate of $(0.12) by 50%. This is a 93.81% increase over losses from the same period last year. The company also reported quarterly sales of $256.00K, beating the analyst consensus estimate of $190.00K by 34.74%. This is a 115.13% increase over sales from the same period last year.
August 10, 2023 | 8:14 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Helius Medical Tech reported better than expected Q2 results with losses per share and sales beating analyst estimates. This could potentially lead to a positive market reaction.
Helius Medical Tech reported a smaller loss per share than expected and higher sales, both beating analyst estimates. This positive financial performance could lead to increased investor confidence and a potential rise in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100